TCRR - TCR2 Therapeutics proposes public offering

TCR2 Therapeutics  ([[TCRR]] -0.4%) commences an underwritten public offering of $125M of shares of common stock.Underwriter's option to purchase up to an additional $18.75M shares.Actual size and terms yet to be finalised.Company intends to use the net proceeds to advance its clinical and earlier stage programs and for research and development, working capital and general corporate purposes.

For further details see:

TCR2 Therapeutics proposes public offering